1. Home
  2. OIG vs PACB Comparison

OIG vs PACB Comparison

Compare OIG & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OIG

Orion180 Insurance Group Inc. Class A common stock

N/A

Current Price

$9.05

Market Cap

582.7M

Sector

N/A

ML Signal

N/A

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

SELL

Current Price

$2.11

Market Cap

521.8M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
OIG
PACB
Founded
2018
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
582.7M
521.8M
IPO Year
2026
2010

Fundamental Metrics

Financial Performance
Metric
OIG
PACB
Price
$9.05
$2.11
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $2.40
AVG Volume (30 Days)
665.0K
★ 13.8M
Earning Date
11-22-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $93,468,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.04
52 Week Low
$7.78
$1.07
52 Week High
$12.06
$3.44

Technical Indicators

Market Signals
Indicator
OIG
PACB
Relative Strength Index (RSI) 32.93 55.34
Support Level $7.78 $1.27
Resistance Level $10.55 $2.73
Average True Range (ATR) 0.87 0.28
MACD -0.07 0.02
Stochastic Oscillator 45.21 34.79

Price Performance

Historical Comparison
OIG
PACB

About OIG Orion180 Insurance Group Inc. Class A common stock

Orion180 Insurance Group Inc operating as an insurance holding company. It is a founder-led, technology-focused, high-growth, high-margin specialty insurance group delivering insurance solutions with a growing footprint across the United States. The group operates in two segments: Services and Underwriting. The Services segment includes technology-enabled policy servicing operations, including intercompany revenue earned through service arrangements between the Services and Underwriting segments. The Underwriting segment includes a conventional, regulated insurance model focused on risk selection, pricing, and statutory capital management. The segment also includes a segregated cell designed to assume reinsurance risk.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Share on Social Networks: